Literature DB >> 26811600

Complete radiotherapy response in rectal cancer: A review of the evidence.

Daniel G Couch1, David M Hemingway1.   

Abstract

Complete response to chemoradiotherapy for rectal cancer is becoming a common clinical entity. Techniques to diagnose complete response and how to survey these patients without operative intervention are still unclear. We review the most recent evidence. Barriers to firm conclusions regarding this are heterogeneity of diagnostic definitions, differing surveillance protocols, and a lack of randomised studies.

Entities:  

Keywords:  Cancer; Chemoradiotherapy; Complete; Rectum; Response

Mesh：

Year:  2016        PMID： 26811600      PMCID： PMC4716052          DOI： 10.3748/wjg.v22.i2.467

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  33 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy.

Authors:  Angelita Habr-Gama; Rodrigo O Perez; Igor Proscurshim; Fábio G Campos; Wladimir Nadalin; Desiderio Kiss; Joaquim Gama-Rodrigues
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

Review 3.  Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer.

Authors:  S T Martin; H M Heneghan; D C Winter
Journal:  Br J Surg       Date:  2012-02-23       Impact factor: 6.939

4.  Surveillance after neoadjuvant therapy in advanced rectal cancer with complete clinical response can have comparable outcomes to total mesorectal excision.

Authors:  Radhika K Smith; Robert D Fry; Najjia N Mahmoud; E Carter Paulson
Journal:  Int J Colorectal Dis       Date:  2015-03-19       Impact factor: 2.571

5.  Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12/PRODIGE 2 randomized trial.

Authors:  Jean-Pierre Gérard; Emmanuel Chamorey; Sophie Gourgou-Bourgade; Karène Benezery; Guy de Laroche; Marc-André Mahé; Valérie Boige; Béata Juzyna
Journal:  Radiother Oncol       Date:  2015-04-24       Impact factor: 6.280

6.  Accuracy of endoscopic ultrasound to assess tumor response after neoadjuvant treatment in rectal cancer: can we trust the findings?

Authors:  Carlos Pastor; Jose Carlos Subtil; Jesus Sola; Jorge Baixauli; Carmen Beorlegui; Leire Arbea; Javier Aristu; Jose Luis Hernandez-Lizoain
Journal:  Dis Colon Rectum       Date:  2011-09       Impact factor: 4.585

7.  Relationship between pathologic T-stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer.

Authors:  Salvatore Pucciarelli; Carlo Capirci; Urso Emanuele; Paola Toppan; Maria Luisa Friso; Gian Maria Pennelli; Giovanni Crepaldi; Lara Pasetto; Donato Nitti; Mario Lise
Journal:  Ann Surg Oncol       Date:  2005-02-04       Impact factor: 5.344

8.  Mesorectal excision for rectal cancer.

Authors:  J K MacFarlane; R D Ryall; R J Heald
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

9.  Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer.

Authors:  Glenda G Callender; Prajnan Das; Miguel A Rodriguez-Bigas; John M Skibber; Christopher H Crane; Sunil Krishnan; Marc E Delclos; Barry W Feig
Journal:  Ann Surg Oncol       Date:  2009-10-22       Impact factor: 5.344

10.  Endorectal ultrasound of T3 and T4 rectal cancers after preoperative chemoradiation.

Authors:  P R Williamson; M D Hellinger; S W Larach; A Ferrara
Journal:  Dis Colon Rectum       Date:  1996-01       Impact factor: 4.585
View more
  4 in total

Review 1.  Radiotherapy resistance: identifying universal biomarkers for various human cancers.

Authors:  Irina Larionova; Militsa Rakina; Elena Ivanyuk; Yulia Trushchuk; Alena Chernyshova; Evgeny Denisov
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-03       Impact factor: 4.322

Review 2.  Recent advances in the management of rectal cancer: No surgery, minimal surgery or minimally invasive surgery.

Authors:  Joseph M Plummer; Pierre-Anthony Leake; Matthew R Albert
Journal:  World J Gastrointest Surg       Date:  2017-06-27

3.  A Case with Rectal Cancer Relapses After Clinical Complete Remission Following Neoadjuvant Chemoradiotherapy.

Authors:  Ping-Bao Zhang; Zi-Li Huang; Jia-Bei Li; Xiu-Yan Huang
Journal:  Cancer Manag Res       Date:  2019-12-27       Impact factor: 3.989

Review 4.  The Role of Micro-RNAs and Circulating Tumor Markers as Predictors of Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.

Authors:  Fatima Domenica Elisa De Palma; Gaetano Luglio; Francesca Paola Tropeano; Gianluca Pagano; Maria D'Armiento; Guido Kroemer; Maria Chiara Maiuri; Giovanni Domenico De Palma
Journal:  Int J Mol Sci       Date:  2020-09-24       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.